Drug-resistant bacterial infection
Conditions
Interventions
Phage therapy group:Nebulized inhaled phage for the treatment of drug-resistant bacterial infections
Sponsors
Shenzhen People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 95 Years
Inclusion criteria
Inclusion criteria: (1) Patients 18-95 years of age with multiple drug-attached bacterial infections of the lungs who are unable to benefit from treatment except for tumors and other end-stage diseases (based on the results of drug sensitivity testing at our institution); (2) Drug-resistant bacteria are sensitive to phage; (3) Subjects and family members (or guardians) fully read, understood and signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Bacterial infections can be effectively controlled by antibiotic therapy; (2) Local administration to the respiratory tract cannot be performed; (3) Exceeding the unit's medical service load; (4) Thinkers who are judged by the investigator to be unsuitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Laboratory Judgment Criteria;Clinical judgment criteria; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory indicators;Security Indicators;Microbiological indicators;Imaging indicators; | — |
Countries
China
Contacts
Public ContactLiu xueyan
Shenzhen People's Hospital
Outcome results
None listed